Indian equity markets saw mild gains recently, driven by select largecap stocks despite ongoing FII outflows and rupee weakness. In this dynamic environment, traders are closely watching specific buzzing stocks. Laxmikant Shukla, Technical Research Analyst at YES Securities, has provided detailed technical analysis and trading recommendations for BSE Ltd, Cipla Ltd, and Dr. Reddy's Laboratories Ltd, outlining target prices and crucial stop-loss levels for each.
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories appears poised for a significant bullish breakout following a period of consolidation. Recent price movements indicate renewed upward momentum, with the stock trading comfortably above its key moving averages. The daily Relative Strength Index (RSI) has also shown a positive crossover, reinforcing the bullish sentiment. This technical setup suggests a potential move towards a target price of Rs 1,440. YES Securities recommends buying Dr. Reddy's above Rs 1,345, with a strict stop-loss set at Rs 1,300, offering a favorable risk-reward proposition as the stock looks set to resume its upward trajectory.
BSE Ltd
BSE Ltd is exhibiting a robust technical structure, characterized by a consistent pattern of higher highs and higher lows, signaling sustained bullish momentum. The stock recently surpassed its previous week’s swing high and closed with a strong bullish candle, further indicating continued upward strength. The overall chart pattern points towards additional upside potential, with the next target anticipated around Rs 4,500. Traders may consider accumulating BSE shares on dips, specifically within the Rs 4,000–4,050 range. A stop-loss should be placed below Rs 3,850 to maintain a favorable risk-reward profile while the uptrend remains intact.
Cipla Ltd
Cipla has demonstrated a resilient rebound from its recent low of Rs 1,165, though it is currently encountering resistance near its 200-day Simple Moving Average (SMA) in the Rs 1,440–1,450 zone. Despite this hurdle, the Moving Average Convergence Divergence (MACD) indicator is turning bullish, and the RSI still has ample room for upward movement, suggesting that buying momentum persists. A decisive daily close above the Rs 1,440–1,450 resistance band would confirm a breakout, potentially paving the way for an upward move towards the Rs 1,590 level. Conversely, if the stock fails to surpass this resistance, it could lead to a healthy corrective pullback towards the Rs 1,380 and Rs 1,340 support levels, allowing the stock to stabilize before its next upward move. The recommended stop-loss for Cipla is Rs 1,380.
Disclaimer: This article provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.